China SXT Pharmaceuticals (SXTC) News Today → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free SXTC Stock Alerts $1.05 +0.02 (+1.94%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJAGX, BSGM and SXTC among mid-day moversmsn.com - April 16 at 12:56 PMmarketbeat.com - April 16 at 9:52 AMChina SXT Pharmaceuticals Inc.wsj.com - February 23 at 5:50 PMChina SXT Pharmaceuticals Stock (NASDAQ:SXTC) Insider Tradesbenzinga.com - February 23 at 2:49 AMChina SXT Pharmaceuticals, Inc. (SXTC)finance.yahoo.com - February 17 at 1:28 AMDow Down 100 Points; US Manufacturing PMI Falls In Decembermarkets.businessinsider.com - January 2 at 12:52 PMChina SXT Pharma Continues To Spikenasdaq.com - December 31 at 12:49 PMChina SXT Pharmaceuticals Inc Ordinary Shares SXTCmorningstar.com - December 20 at 12:33 AMChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rulefinance.yahoo.com - October 26 at 8:13 PMChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rulefinance.yahoo.com - October 26 at 8:13 PMmarketbeat.com - October 5 at 9:46 AMChina SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Splitfinanznachrichten.de - October 4 at 3:53 PMChina SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5markets.businessinsider.com - October 4 at 10:53 AMChina SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Splitfinance.yahoo.com - October 4 at 10:53 AMWhy Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?investorplace.com - September 7 at 9:05 AMSXTC China SXT Pharmaceuticals, Inc.seekingalpha.com - August 25 at 8:57 AMWhy Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?markets.businessinsider.com - August 21 at 8:53 AMChina SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)finance.yahoo.com - August 2 at 10:21 AMChina SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rulefinance.yahoo.com - May 10 at 3:51 PMInsiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% dropfinance.yahoo.com - March 29 at 1:17 PMChina says talks to include Paxlovid in its insurance drug list failreuters.com - January 10 at 6:18 PMChina SXT Pharmaceuticals Stock (NASDAQ:SXTC), Quotes and News Summarybenzinga.com - January 5 at 9:57 PMChina SXT Pharmaceuticals announces 1-for-20 reverse stock splitseekingalpha.com - May 18 at 4:50 PMWhy Is China SXT Pharmaceuticals (SXTC) Stock Up Today?investorplace.com - March 29 at 1:06 PMChina SXT Pharmaceuticals climbs on heavy volumeseekingalpha.com - March 29 at 11:25 AMChina SXT Pharmaceuticals to raise $2.8M in convertible promissory note offeringseekingalpha.com - March 15 at 7:44 AMChina SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Millionbenzinga.com - March 14 at 11:19 PMChina SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotmentfinance.yahoo.com - January 20 at 3:26 PMAegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).finance.yahoo.com - January 20 at 3:26 PMChina SXT Pharmaceuticals Shares Plunge On $3.5M Equity Raise Issued At Steep Discountfinance.yahoo.com - January 18 at 12:28 PMChina SXT Pharmaceuticals slumps on pricing $3.5M stock, pre-funded warrants offeringseekingalpha.com - January 18 at 7:28 AMChina SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Sharesfinance.yahoo.com - January 18 at 7:28 AMChina SXT Pharma announces proposed public offering of shares, prefunded warrantsseekingalpha.com - January 14 at 8:24 PMChina SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Sharesfinance.yahoo.com - January 14 at 8:24 PMChina SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejinfinance.yahoo.com - January 14 at 3:24 PMChina SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspectionfinance.yahoo.com - October 18 at 9:41 AM Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. SXTC Media Mentions By Week SXTC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SXTC News Sentiment▼-1.000.32▲Average Medical News Sentiment SXTC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SXTC Articles This Week▼10▲SXTC Articles Average Week Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Allarity Therapeutics News Aditxt News Ampio Pharmaceuticals News Aptevo Therapeutics News Athersys News Bellerophon Therapeutics News Evelo Biosciences News Evofem Biosciences News SciSparc News Biodexa Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SXTC) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
